Abstract
A risk indicator is generally defined as a factor associated with the occurrence of a particular disease. The association between a risk factor and a disease is often, although not necessarily, causal. Risk is usually expressed as the relative increase or decrease in the probability of having or acquiring the disease when the risk indicator moves from one level to another. Risk estimates include random biological variation in the strength of the association between a particular risk factor and an illness. Thus, when a patient is a carrier of a certain risk factor, this does not automatically imply that he or she will become diseased.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Selected references
Amery A, Fagard R, Staessen J (1987): Recent data on changes in lipid metabolism induced by hypotensive drugs. Cuir Opinion Cardiol 2: 769–774.
Carr SJ, Thomas TH, Laker MF, Wilkinson R (1990): Elevated sodium—lithium countertransport: a familial marker of hyperlipidaemia and hypertension. J Hypertension 8: 139–146.
Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, Godwin J, Qizilbash N, Taylor JO, Hennekens CH (1990): Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1: 827–838.
Fielding JE (1985): Smoking: health effects and control. NEngl JMed 313: 491–498.
Handbook of Hypertension (Series Editors WH Birkenhäger, JL Reid). Volume 12. Hypertension in the Elderly (Eds. A Amery, J Staessen). Elsevier, Amsterdam, 1989.
Handbook of Hypertension (Series Editors WH Birkenhäger, JL Reid). Volume 6.Epidemiology of Hypertension. (Ed. CJ Bulpitt). Elsevier, Amsterdam, 1985.
Kannel WB (1974): Role of blood pressure in cardiovascular epidemiology. Prog Cardiovasc Dis 17: 5–24.
Kannel WB (1976): Some lessons in cardiovascular epidemiology from Framingham. Am J Cardiol 37: 269–282.
Kannel WB (1990): Contribution of the Framingham Study to preventive cardiology. JAm Coll Cardiol 15: 206–211.
Kaplan NM (1989): The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyeridaemia, and hypertension. Arch Intern Med 149: 1514–1520.
Klatsky AL, Friedman GD, Siegelaub AB (1981): Alcohol use and cardiovascular disease: the Kaiser-Permanente experience. Circulation 64 (Suppl III): III32–III41.
Levy D (1988): Left ventricular hypertrophy. Epidemiological insights from the Framingham Heart Study. Drugs Suppl 5: 1–5.
Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP (1990): Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322: 1561–1566.
MacMahon SW, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J (1990): Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 335: 765–774.
Stadel BV (1981): Oral contraceptives and cardiovascular disease. NEngl JMed 305: 672–677.
Staessen J, Fagard R, Van Hoof R, Amery A (1988): Mortality in various intervention trials in elderly hypertensive patients. Eur Heart J 9: 215–222.
Staessen J, Fagard R, Amery A (1988): The relationship between body weight and blood pressure. JHuman Hypertension 2: 207–217.
Staessen J, Bulpitt CJ, Fagard R, Lijnen P, Amery P (1989): The influence of menopause on blood pressure. J Human Hypertension 3: 427–433.
Stampfer MJ, Willett WC, Colditz GA, Speizer FE, Hennekens CH (1988): Prospective study of past use of oral contraceptive agents and risk of cardiovascular diseases. N Engl J Med 319: 1313–1317.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Staessen, J., Fagard, R., Amery, A. (1990). Cardiovascular risk associated with hypertension; interactions with other risk indicators. In: Birkenhäger, W.H. (eds) Practical Management of Hypertension. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-3724-9_3
Download citation
DOI: https://doi.org/10.1007/978-94-011-3724-9_3
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-5655-7
Online ISBN: 978-94-011-3724-9
eBook Packages: Springer Book Archive